Non-Synonymous Mutation Analysis of SARS-CoV-2 ORF3a in Indonesia
Abstract
Background: The report of mutation sites ORF3a SARS CoV-2 in Indonesia is still limited. Some research showed that mutations in ORF3a protein might alter SARS-CoV-2 pathogenesis. Observation of new variants should be conducted as a risk monitoring framework.
Materials and method: We assessed the impact of mutations in ORF3a protein by analyzing 3,751 SARS-CoV-2 DNA sequences from the GISAID database from March 2020 until July 2021. The whole-genome sequences were aligned using Clustal Omega Multiple Sequence Alignment from EMBL-EBI and analyzed using BioEdit version 7.2.5 software. The reference whole genome sequence was taken from the Genbank database with accession number NC045512. We excluded the samples containing N letters due to inaccurate reading. Effect of point mutations on protein structure was analyzed using PredictProtein (https://predictprotein.org) and Protein Variation Effect Analyzer (PROVEAN) v1.1.3. online software.
Results: We identified five most frequent non-synonymous mutations in ORF3a protein of SARS-CoV-2 which were Q57H (58.04%), S26L (27.25%), S220I (10.37%), D155H (8.98%), and P104S (5.47%).
Conclusion: These mutation data showed the phenomenon of amino acid changes in ORF3a SARS-CoV-2 in Indonesia until July 2021. The implication of this mutation needs to be determined in further studies.
Keywords: Indonesia, mutations, non-synonymous, SARS-CoV-2, whole genome
Full Text:
PDFReferences
van Dorp L, Acman M, Richard D, Shaw LP, Ford CE, Ormond L, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020; 83: 104351, CrossRef.
Satuan Tugas Penanganan COVID-19 [Internet]. 2021. Peta Sebaran [updated 2021 Agt 20; cited 2021 Agt 20]. Available from: https://covid19.go.id/.
Majumdar P, Niyogi S. ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection. Epidemiol Infect. 2020; 148: e262, CrossRef.
Azad GK, Khan PK. Variations in Orf3a protein of SARS-CoV-2 alter its structure and function. Biochem Biophys Rep. 2021 ;26: 100933, CrossRef.
Chu DKW, Hui KPY, Gu H, Ronald LW, Krishnan P, Daisy, YMN, et al. Introduction of ORF3a-Q57H SARS-CoV-2 variant causing fourth epidemic wave of COVID-19, Hong Kong, China. Emerging Infectious Diseases. Emerg Infect Dis. 2021; 27(5): 15, CrossRef.
GISAID - Initiative [Internet]. Freunde von GISAID e.V; 2008-2021 [cited 2021 July 31]. Available from: https://www.gisaid.org/.
Vemaps [Image on internet]. Outline Map of Indonesia with Provinces [cited 2021 Agt 20]. Available from: https://vemaps.com/.
Banerkee S, Seal S, Dey R, Mondal KK, Bhattacharjee P. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America. J Med Virol. 2021; 93(3): 1428-35, CrossRef.
J Craig Venter Institute [Internet]. PROVEAN Score [cited 2021 Aug 31]. Available from: http://provean.jcvi.org/.
Rehman S, Mahmood T, Aziz E, Batool R. Identification of novel mutations in SARS-CoV-2 isolates from Turkey. Arch Virol. 2020; 165(12): 2937-44, CrossRef.
Issa E, Merhi G, Panossian B, Salloum T, Tokajian S. SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis. mSystems. 2020; 5(3): e00266-20, CrossRef.
Bianchi M, Borsetti A, Ciccozzi M, Pascarella S. SARS-CoV-2 ORF3a: Mutability and function. Int J Biol Macromol. 2021; 170: 820-6, CrossRef.
Tan, YJ. The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein. Virol J. 2005; 2: 5, CrossRef.
Wu S, Tian C, Liu P, Guo D, Zheng W, Huang X, et al. Effects of SARS‐CoV‐2 mutations on protein structures and intraviral protein–protein interactions. J Med Virol. 2020; 93(4): 2132-2140, CrossRef.
DOI: https://doi.org/10.21705/mcbs.v6i1.221
Copyright (c) 2022 Cell and BioPharmaceutical Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
Cell and BioPharmaceutical Institute
